A Phase II, Multicenter, Open-Label, Two-Cohort Trial Evaluating the Efficacy and Safety of GDC-0449 in Operable Basal Cell Carcinoma (BCC)

Status
Active
Cancer Type
Skin Cancer (Non-Melanoma)
Trial Phase
Phase II
Eligibility
21 and over, Male and Female
Study Type
Treatment
NCD ID
NCT01201915
Protocol IDs
SHH4812g (primary)
GS01354
Study Sponsor
Genentech Incorporated

Summary

This is a two-cohort, open-label study of GDC-0449 in new (non-recurrent), clinically diagnosed (not yet biopsied), operable BCC of the nodular subtype.